Endogenous versus exogenous growth factor regulation of articular chondrocytes

Shuiliang Shi1, Albert G Chan, Scott Mercer

  • 1Department of Orthopaedic Surgery, Indiana University School of Medicine, 541 Clinical Drive, CL600, Indianapolis, Indiana, 46202-5111.

Insights

Delivery method impacts growth factor effectiveness for cartilage repair. Insulin-like growth factor-I (IGF-I) works well with gene or protein therapy, but transforming growth factor-beta1 (TGF-β1) gene therapy is less effective due to activation issues.

Area of Science:

  • Biochemistry
  • Regenerative Medicine
  • Cell Biology

Background:

  • Articular chondrocytes are key targets for cartilage repair.
  • Growth factors can be delivered via exogenous proteins or gene therapy for endogenous production.
  • The optimal delivery method for growth factors in cartilage repair remains unclear.

Purpose of the Study:

  • To compare the effectiveness of exogenous versus endogenous delivery of insulin-like growth factor-I (IGF-I) and transforming growth factor-beta1 (TGF-β1) on articular chondrocyte function.
  • To investigate the influence of delivery method on chondrocyte DNA content, glycosaminoglycan production, and aggrecan gene expression.

Main Methods:

  • Adult bovine articular chondrocytes were treated with recombinant IGF-I and TGF-β1 proteins (exogenous).
  • Chondrocytes were also treated with genes encoding IGF-I and TGF-β1 for endogenous production (gene therapy).
  • Effects on DNA content, glycosaminoglycan production, and aggrecan gene expression were measured.

Main Results:

  • IGF-I demonstrated similar anabolic effects on chondrocytes regardless of whether it was delivered exogenously or endogenously.
  • Exogenous TGF-β1 significantly stimulated chondrocyte reparative functions.
  • Endogenous TGF-β1 showed limited effects unless the transgene product was activated, suggesting challenges in latent complex conversion.

Conclusions:

  • Effective growth factor delivery strategies for articular cartilage repair vary depending on the specific growth factor.
  • Both gene therapy and protein therapy are viable options for IGF-I delivery.
  • TGF-β1 gene therapy efficacy may be limited by chondrocytes' capacity to activate the latent form of the growth factor.

Related Concept Videos

Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
6.4K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.5K